A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Raul D. e MARANHÃO, Raul Cavalcante. What is new in familial hypercholesterolemia?. Current Opinion in Lipidology, v. 25, n. 3, p. 183-188, 2014Tradução . . Disponível em: https://doi.org/10.1097/MOL.0000000000000073. Acesso em: 08 nov. 2024.
APA
Santos, R. D., & Maranhão, R. C. (2014). What is new in familial hypercholesterolemia? Current Opinion in Lipidology, 25( 3), 183-188. doi:10.1097/MOL.0000000000000073
NLM
Santos RD, Maranhão RC. What is new in familial hypercholesterolemia? [Internet]. Current Opinion in Lipidology. 2014 ; 25( 3): 183-188.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1097/MOL.0000000000000073
Vancouver
Santos RD, Maranhão RC. What is new in familial hypercholesterolemia? [Internet]. Current Opinion in Lipidology. 2014 ; 25( 3): 183-188.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1097/MOL.0000000000000073
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANGILI, Otavio Celeste et al. Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects. Atherosclerosis, v. 233, n. 1, p. 319-325, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2013.12.008. Acesso em: 08 nov. 2024.
APA
Mangili, O. C., Gagliardi, A. C. M., Mangili, L. C., Mesquita, C. H., Cesar, L. A. M., Tanaka, A., et al. (2014). Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects. Atherosclerosis, 233( 1), 319-325. doi:10.1016/j.atherosclerosis.2013.12.008
NLM
Mangili OC, Gagliardi ACM, Mangili LC, Mesquita CH, Cesar LAM, Tanaka A, Schaefer EJ, Maranhão RC, Santos RD. Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects [Internet]. Atherosclerosis. 2014 ; 233( 1): 319-325.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2013.12.008
Vancouver
Mangili OC, Gagliardi ACM, Mangili LC, Mesquita CH, Cesar LAM, Tanaka A, Schaefer EJ, Maranhão RC, Santos RD. Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects [Internet]. Atherosclerosis. 2014 ; 233( 1): 319-325.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2013.12.008
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARNEIRO, Marcia M. et al. The removal from plasma of chylomicrons and remnants is reduced in heterozygous familial hypercholesterolemia subjects with identified LDL receptor mutations: Study with artificial emulsions. Atherosclerosis, v. 221, n. 1, p. 268-274, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2011.12.033. Acesso em: 08 nov. 2024.
APA
Carneiro, M. M., Miname, M. H., Gagliardi, A. C., Pereira, C., Pereira, A. C., Krieger, J. E., et al. (2012). The removal from plasma of chylomicrons and remnants is reduced in heterozygous familial hypercholesterolemia subjects with identified LDL receptor mutations: Study with artificial emulsions. Atherosclerosis, 221( 1), 268-274. doi:10.1016/j.atherosclerosis.2011.12.033
NLM
Carneiro MM, Miname MH, Gagliardi AC, Pereira C, Pereira AC, Krieger JE, Maranhão RC, Santos RD. The removal from plasma of chylomicrons and remnants is reduced in heterozygous familial hypercholesterolemia subjects with identified LDL receptor mutations: Study with artificial emulsions [Internet]. Atherosclerosis. 2012 ; 221( 1): 268-274.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2011.12.033
Vancouver
Carneiro MM, Miname MH, Gagliardi AC, Pereira C, Pereira AC, Krieger JE, Maranhão RC, Santos RD. The removal from plasma of chylomicrons and remnants is reduced in heterozygous familial hypercholesterolemia subjects with identified LDL receptor mutations: Study with artificial emulsions [Internet]. Atherosclerosis. 2012 ; 221( 1): 268-274.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2011.12.033
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANHÃO, Raul Cavalcante et al. Lipid transfers to HDL are predictors of precocious clinical coronary heart disease. Clinica Chimica Acta, v. 413, n. 3-4, p. 502-505, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2011.11.011. Acesso em: 08 nov. 2024.
APA
Maranhão, R. C., Freitas, F. R., Strunz, C. M., Santos, R. D., Mansur, A. J., & Mansur, A. P. (2012). Lipid transfers to HDL are predictors of precocious clinical coronary heart disease. Clinica Chimica Acta, 413( 3-4), 502-505. doi:10.1016/j.cca.2011.11.011
NLM
Maranhão RC, Freitas FR, Strunz CM, Santos RD, Mansur AJ, Mansur AP. Lipid transfers to HDL are predictors of precocious clinical coronary heart disease [Internet]. Clinica Chimica Acta. 2012 ; 413( 3-4): 502-505.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.cca.2011.11.011
Vancouver
Maranhão RC, Freitas FR, Strunz CM, Santos RD, Mansur AJ, Mansur AP. Lipid transfers to HDL are predictors of precocious clinical coronary heart disease [Internet]. Clinica Chimica Acta. 2012 ; 413( 3-4): 502-505.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.cca.2011.11.011
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Raul D. et al. Plasma kinetics of free and esterified cholesterol in familial hypercholesterolemia: effects of simvastatin. Lipids, v. 40, n. 7, p. 737-743, 2005Tradução . . Disponível em: https://doi.org/10.1007/s11745-005-1437-6. Acesso em: 08 nov. 2024.
APA
Santos, R. D., Chacra, A. P. M., Morikawa, A. T., Vinagre, C. G. C. de M., & Maranhão, R. C. (2005). Plasma kinetics of free and esterified cholesterol in familial hypercholesterolemia: effects of simvastatin. Lipids, 40( 7), 737-743. doi:10.1007/s11745-005-1437-6
NLM
Santos RD, Chacra APM, Morikawa AT, Vinagre CGC de M, Maranhão RC. Plasma kinetics of free and esterified cholesterol in familial hypercholesterolemia: effects of simvastatin [Internet]. Lipids. 2005 ; 40( 7): 737-743.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1007/s11745-005-1437-6
Vancouver
Santos RD, Chacra APM, Morikawa AT, Vinagre CGC de M, Maranhão RC. Plasma kinetics of free and esterified cholesterol in familial hypercholesterolemia: effects of simvastatin [Internet]. Lipids. 2005 ; 40( 7): 737-743.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1007/s11745-005-1437-6
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPÓSITO, Andrei Carvalho et al. Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment. Journal of the American College of Cardiology, v. 43, n. 12, p. 2225-2232, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2003.11.065. Acesso em: 08 nov. 2024.
APA
Spósito, A. C., Lemos, P. A., Santos, R. D., Hueb, W., Vinagre, C. G. C. de M., Quintella, E., et al. (2004). Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment. Journal of the American College of Cardiology, 43( 12), 2225-2232. doi:10.1016/j.jacc.2003.11.065
NLM
Spósito AC, Lemos PA, Santos RD, Hueb W, Vinagre CGC de M, Quintella E, Carneiro O, Chapman MJ, Ramires JAF, Maranhão RC. Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment [Internet]. Journal of the American College of Cardiology. 2004 ; 43( 12): 2225-2232.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.jacc.2003.11.065
Vancouver
Spósito AC, Lemos PA, Santos RD, Hueb W, Vinagre CGC de M, Quintella E, Carneiro O, Chapman MJ, Ramires JAF, Maranhão RC. Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment [Internet]. Journal of the American College of Cardiology. 2004 ; 43( 12): 2225-2232.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.jacc.2003.11.065
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHACRA, Ana Paula Marte et al. Clearance of a H-3-labeled chylomicron-like emulsion following the acute phase of myocardial infarction. International Journal of Cardiology, v. 93, n. 2-3, p. 181-187, 2004Tradução . . Disponível em: https://doi.org/10.1016/s0167-5273(03)00159-1. Acesso em: 08 nov. 2024.
APA
Chacra, A. P. M., Santos, R. D., Amâncio, R. F., Schreiber, R., Ramires, J. A. F., & Maranhão, R. C. (2004). Clearance of a H-3-labeled chylomicron-like emulsion following the acute phase of myocardial infarction. International Journal of Cardiology, 93( 2-3), 181-187. doi:10.1016/s0167-5273(03)00159-1
NLM
Chacra APM, Santos RD, Amâncio RF, Schreiber R, Ramires JAF, Maranhão RC. Clearance of a H-3-labeled chylomicron-like emulsion following the acute phase of myocardial infarction [Internet]. International Journal of Cardiology. 2004 ; 93( 2-3): 181-187.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/s0167-5273(03)00159-1
Vancouver
Chacra APM, Santos RD, Amâncio RF, Schreiber R, Ramires JAF, Maranhão RC. Clearance of a H-3-labeled chylomicron-like emulsion following the acute phase of myocardial infarction [Internet]. International Journal of Cardiology. 2004 ; 93( 2-3): 181-187.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/s0167-5273(03)00159-1
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Raul D. et al. Familial hypercholesterolemia patients present defects in the removal from plasma of both free and esterified forms of cholesterol that are improved by Simvastatin: study with artificial emulsions. European Heart Journal. London: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 08 nov. 2024. , 2004
APA
Santos, R. D., Chacra, A. P. M., Morikawa, A. T., Silva, V., Ficker, E. S., Vinagre, C. G. C. de M., et al. (2004). Familial hypercholesterolemia patients present defects in the removal from plasma of both free and esterified forms of cholesterol that are improved by Simvastatin: study with artificial emulsions. European Heart Journal. London: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Santos RD, Chacra APM, Morikawa AT, Silva V, Ficker ES, Vinagre CGC de M, Martinez TL da R, Maranhão RC. Familial hypercholesterolemia patients present defects in the removal from plasma of both free and esterified forms of cholesterol that are improved by Simvastatin: study with artificial emulsions. European Heart Journal. 2004 ; 25 48 res.P402.[citado 2024 nov. 08 ]
Vancouver
Santos RD, Chacra APM, Morikawa AT, Silva V, Ficker ES, Vinagre CGC de M, Martinez TL da R, Maranhão RC. Familial hypercholesterolemia patients present defects in the removal from plasma of both free and esterified forms of cholesterol that are improved by Simvastatin: study with artificial emulsions. European Heart Journal. 2004 ; 25 48 res.P402.[citado 2024 nov. 08 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHACRA, Ana Paula Marte et al. Efeitos da metformina e rosiglitazona no metabolismo de quilomícrons em pacientes com síndrome metabólica. Revista da Sociedade de Cardiologia do Estado de São Paulo. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 08 nov. 2024. , 2004
APA
Chacra, A. P. M., Santos, R. D., Silva, V., Vinagre, C., Martinez, T., Ramires, J. A., & Maranhão, R. C. (2004). Efeitos da metformina e rosiglitazona no metabolismo de quilomícrons em pacientes com síndrome metabólica. Revista da Sociedade de Cardiologia do Estado de São Paulo. São Paulo: Faculdade de Medicina, Universidade de São Paulo.
NLM
Chacra APM, Santos RD, Silva V, Vinagre C, Martinez T, Ramires JA, Maranhão RC. Efeitos da metformina e rosiglitazona no metabolismo de quilomícrons em pacientes com síndrome metabólica. Revista da Sociedade de Cardiologia do Estado de São Paulo. 2004 ; 14( 2): 25.[citado 2024 nov. 08 ]
Vancouver
Chacra APM, Santos RD, Silva V, Vinagre C, Martinez T, Ramires JA, Maranhão RC. Efeitos da metformina e rosiglitazona no metabolismo de quilomícrons em pacientes com síndrome metabólica. Revista da Sociedade de Cardiologia do Estado de São Paulo. 2004 ; 14( 2): 25.[citado 2024 nov. 08 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPOSITO, Andrei C. et al. Delayed intravascular catabolism of chylomicron-like emulsions is an independent predictor of coronary artery disease. Atherosclerosis, v. 176, n. 2, p. 397-403, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2004.05.023. Acesso em: 08 nov. 2024.
APA
Sposito, A. C., Ventura, L. I., Vinagre, C. G., Lemos, P. A., Quintella, E., Santos, R. D., et al. (2004). Delayed intravascular catabolism of chylomicron-like emulsions is an independent predictor of coronary artery disease. Atherosclerosis, 176( 2), 397-403. doi:10.1016/j.atherosclerosis.2004.05.023
NLM
Sposito AC, Ventura LI, Vinagre CG, Lemos PA, Quintella E, Santos RD, Carneiro O, Ramires JAF, Maranhão RC. Delayed intravascular catabolism of chylomicron-like emulsions is an independent predictor of coronary artery disease [Internet]. Atherosclerosis. 2004 ; 176( 2): 397-403.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2004.05.023
Vancouver
Sposito AC, Ventura LI, Vinagre CG, Lemos PA, Quintella E, Santos RD, Carneiro O, Ramires JAF, Maranhão RC. Delayed intravascular catabolism of chylomicron-like emulsions is an independent predictor of coronary artery disease [Internet]. Atherosclerosis. 2004 ; 176( 2): 397-403.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2004.05.023
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Raul D. et al. Plasma kinetics of a cholesterol-rich emulsion in subjects with or without coronary artery disease. Journal of Lipid Research, v. 44, n. 3, p. 464-469, 2003Tradução . . Disponível em: https://doi.org/10.1194/jlr.m200331-jlr200. Acesso em: 08 nov. 2024.
APA
Santos, R. D., Hueb, W. A., Oliveira, A. A., Ramires, J. A. F., & Maranhão, R. C. (2003). Plasma kinetics of a cholesterol-rich emulsion in subjects with or without coronary artery disease. Journal of Lipid Research, 44( 3), 464-469. doi:10.1194/jlr.m200331-jlr200
NLM
Santos RD, Hueb WA, Oliveira AA, Ramires JAF, Maranhão RC. Plasma kinetics of a cholesterol-rich emulsion in subjects with or without coronary artery disease [Internet]. Journal of Lipid Research. 2003 ; 44( 3): 464-469.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1194/jlr.m200331-jlr200
Vancouver
Santos RD, Hueb WA, Oliveira AA, Ramires JAF, Maranhão RC. Plasma kinetics of a cholesterol-rich emulsion in subjects with or without coronary artery disease [Internet]. Journal of Lipid Research. 2003 ; 44( 3): 464-469.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1194/jlr.m200331-jlr200
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPÓSITO, Andrei Carvalho et al. Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins. Atherosclerosis, v. 166, n. 2, p. 311-321, 2003Tradução . . Disponível em: https://doi.org/10.1016/s0021-9150(02)00334-9. Acesso em: 08 nov. 2024.
APA
Spósito, A. C., Santos, R. D., Amâncio, R. F., Ramires, J. A. F., Chapman, M. J., & Maranhão, R. C. (2003). Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins. Atherosclerosis, 166( 2), 311-321. doi:10.1016/s0021-9150(02)00334-9
NLM
Spósito AC, Santos RD, Amâncio RF, Ramires JAF, Chapman MJ, Maranhão RC. Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins [Internet]. Atherosclerosis. 2003 ; 166( 2): 311-321.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/s0021-9150(02)00334-9
Vancouver
Spósito AC, Santos RD, Amâncio RF, Ramires JAF, Chapman MJ, Maranhão RC. Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins [Internet]. Atherosclerosis. 2003 ; 166( 2): 311-321.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/s0021-9150(02)00334-9
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHACRA, Ana Paula Marte et al. Avaliação do metabolismo de quilomícrons na fase aguda do infarto do miocárdio. Revista da Sociedade de Cardiologia do Estado de São Paulo. São Paulo: Socesp. . Acesso em: 08 nov. 2024. , 2002
APA
Chacra, A. P. M., Santos, R. D., Amâncio, R. F., Schreiber, R., Ramires, J. A. F., & Maranhão, R. C. (2002). Avaliação do metabolismo de quilomícrons na fase aguda do infarto do miocárdio. Revista da Sociedade de Cardiologia do Estado de São Paulo. São Paulo: Socesp.
NLM
Chacra APM, Santos RD, Amâncio RF, Schreiber R, Ramires JAF, Maranhão RC. Avaliação do metabolismo de quilomícrons na fase aguda do infarto do miocárdio. Revista da Sociedade de Cardiologia do Estado de São Paulo. 2002 ; 12( 2): 23 res. 014.[citado 2024 nov. 08 ]
Vancouver
Chacra APM, Santos RD, Amâncio RF, Schreiber R, Ramires JAF, Maranhão RC. Avaliação do metabolismo de quilomícrons na fase aguda do infarto do miocárdio. Revista da Sociedade de Cardiologia do Estado de São Paulo. 2002 ; 12( 2): 23 res. 014.[citado 2024 nov. 08 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPOSITO, Andrei C. et al. Intravascular lipolysis of TG-rich particles is accelerated in patients with heart failure. Circulation - Journal of the American Heart Association. Baltimore: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 08 nov. 2024. , 2002
APA
Sposito, A. C., Vinagre, C. G. C., Santos, R. D., Stolf, N. A. G., Bocchi, E. A., Ramires, J. A. F., & Maranhão, R. C. (2002). Intravascular lipolysis of TG-rich particles is accelerated in patients with heart failure. Circulation - Journal of the American Heart Association. Baltimore: Faculdade de Medicina, Universidade de São Paulo.
NLM
Sposito AC, Vinagre CGC, Santos RD, Stolf NAG, Bocchi EA, Ramires JAF, Maranhão RC. Intravascular lipolysis of TG-rich particles is accelerated in patients with heart failure. Circulation - Journal of the American Heart Association. 2002 ; 106( 19): II-572.[citado 2024 nov. 08 ]
Vancouver
Sposito AC, Vinagre CGC, Santos RD, Stolf NAG, Bocchi EA, Ramires JAF, Maranhão RC. Intravascular lipolysis of TG-rich particles is accelerated in patients with heart failure. Circulation - Journal of the American Heart Association. 2002 ; 106( 19): II-572.[citado 2024 nov. 08 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPÓSITO, Andrei Carvalho et al. LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease. Atherosclerosis, v. 161, n. 2, p. 447-453, 2002Tradução . . Disponível em: https://doi.org/10.1016/s0021-9150(01)00661-x. Acesso em: 08 nov. 2024.
APA
Spósito, A. C., Santos, R. D., Hueb, W., Ventura, L. I., Vinagre, C. G. C., Ramires, J. A. F., & Maranhão, R. C. (2002). LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease. Atherosclerosis, 161( 2), 447-453. doi:10.1016/s0021-9150(01)00661-x
NLM
Spósito AC, Santos RD, Hueb W, Ventura LI, Vinagre CGC, Ramires JAF, Maranhão RC. LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease [Internet]. Atherosclerosis. 2002 ; 161( 2): 447-453.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/s0021-9150(01)00661-x
Vancouver
Spósito AC, Santos RD, Hueb W, Ventura LI, Vinagre CGC, Ramires JAF, Maranhão RC. LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease [Internet]. Atherosclerosis. 2002 ; 161( 2): 447-453.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/s0021-9150(01)00661-x
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPÓSITO, Andrei Carvalho et al. Effects of etofibrate upon the metabolism of chylomicron-like emulsions in patients with coronary artery disease. Atherosclerosis, v. 154, n. 2, p. 455-461, 2001Tradução . . Disponível em: https://doi.org/10.1016/s0021-9150(00)00491-3. Acesso em: 08 nov. 2024.
APA
Spósito, A. C., Maranhão, R. C., Vinagre, C. G. C., Santos, R. D., & Ramires, J. A. F. (2001). Effects of etofibrate upon the metabolism of chylomicron-like emulsions in patients with coronary artery disease. Atherosclerosis, 154( 2), 455-461. doi:10.1016/s0021-9150(00)00491-3
NLM
Spósito AC, Maranhão RC, Vinagre CGC, Santos RD, Ramires JAF. Effects of etofibrate upon the metabolism of chylomicron-like emulsions in patients with coronary artery disease [Internet]. Atherosclerosis. 2001 ; 154( 2): 455-461.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/s0021-9150(00)00491-3
Vancouver
Spósito AC, Maranhão RC, Vinagre CGC, Santos RD, Ramires JAF. Effects of etofibrate upon the metabolism of chylomicron-like emulsions in patients with coronary artery disease [Internet]. Atherosclerosis. 2001 ; 154( 2): 455-461.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/s0021-9150(00)00491-3
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Raul D. et al. The Effects of gemfibrozil upon the metabolism of chylomicron-like emulsions in patients with endogenous hypertriglyceridemia. Cardiovascular Research, v. 49, n. 2, p. 456-465, 2001Tradução . . Disponível em: https://doi.org/10.1016/s0008-6363(00)00274-1. Acesso em: 08 nov. 2024.
APA
Santos, R. D., Ventura, L. I., Spósito, A. C., Schreiber, R., Ramires, J. A. F., & Maranhão, R. C. (2001). The Effects of gemfibrozil upon the metabolism of chylomicron-like emulsions in patients with endogenous hypertriglyceridemia. Cardiovascular Research, 49( 2), 456-465. doi:10.1016/s0008-6363(00)00274-1
NLM
Santos RD, Ventura LI, Spósito AC, Schreiber R, Ramires JAF, Maranhão RC. The Effects of gemfibrozil upon the metabolism of chylomicron-like emulsions in patients with endogenous hypertriglyceridemia [Internet]. Cardiovascular Research. 2001 ; 49( 2): 456-465.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/s0008-6363(00)00274-1
Vancouver
Santos RD, Ventura LI, Spósito AC, Schreiber R, Ramires JAF, Maranhão RC. The Effects of gemfibrozil upon the metabolism of chylomicron-like emulsions in patients with endogenous hypertriglyceridemia [Internet]. Cardiovascular Research. 2001 ; 49( 2): 456-465.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/s0008-6363(00)00274-1
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Raul D. et al. Levels of lipoprotein (a) in pulmonary arterial hypertension. Cardiology in the Young, v. 11, p. 25-29, 2001Tradução . . Disponível em: https://doi.org/10.1017/s1047951100012385. Acesso em: 08 nov. 2024.
APA
Santos, R. D., Foronda, A., Ramires, J. A. F., & Maranhão, R. C. (2001). Levels of lipoprotein (a) in pulmonary arterial hypertension. Cardiology in the Young, 11, 25-29. doi:10.1017/s1047951100012385
NLM
Santos RD, Foronda A, Ramires JAF, Maranhão RC. Levels of lipoprotein (a) in pulmonary arterial hypertension [Internet]. Cardiology in the Young. 2001 ; 11 25-29.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1017/s1047951100012385
Vancouver
Santos RD, Foronda A, Ramires JAF, Maranhão RC. Levels of lipoprotein (a) in pulmonary arterial hypertension [Internet]. Cardiology in the Young. 2001 ; 11 25-29.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1017/s1047951100012385